Literature DB >> 167193

Polyadenylic acid on poliovirus RNA. II. poly(A) on intracellular RNAs.

D H Spector, D Baltimore.   

Abstract

The content, size, and mechanism of synthesis of 3'-terminal poly(A) on the various intracellular species of poliovirus RNA have been examined. All viral RNA species bound to poly(U) filters and contained RNase-resistant stretches of poly(A) which could be analyzed by electrophoresis in polyacrylamide gels. At 3 h after infection, the poly(A) on virion RNA, relicative intermediate RNA, polyribosomal RNA, and total cytoplasmic 35S RNA was heterogeneous in size with an average length of 75 nucleotides. By 6 h after infection many of the intracellular RNA's had poly(A) of over 150 nucleotides in length, but the poly(A) in virion RNA did not increase in size suggesting that the amount of poly(A) which can be encapsidated is limited. At all times, the double-stranded poliovirus RNA molecules had poly(A) of 150 to 200 nucleotides. Investigation of the kinetics of poly(A) appearance in the replicative intermediate and in finished 35S molecules indicated that poly(A) is the last portion of the 35S RNA to be synthesized; no nascent poly(A) could be detected in the replicative intermediate. Although this result indicates that poliovirus RNA is synthesized 5' leads to 3' like other RNA's, it also suggests that much of the poly(A) found in the replicative intermediate is an artifact possibly arising from the binding of finished 35S RNA molecules to the replicative intermediate during extraction. The addition of poly(A) to 35S RNA molecules was not sensitive to guanidene.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 167193      PMCID: PMC354609     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  A CYTOPLASMIC STRUCTURE INVOLVED IN THE SYNTHESIS AND ASSEMBLY OF POLIOVIRUS COMPONENTS.

Authors:  S PENMAN; Y BECKER; J E DARNELL
Journal:  J Mol Biol       Date:  1964-04       Impact factor: 5.469

2.  Sequence studies of poliovirus RNA. III. Polyuridylic acid and polyadenylic acid as components of the purified poliovirus replicative intermediate.

Authors:  Y Yogo; E Wimmer
Journal:  J Mol Biol       Date:  1975-03-05       Impact factor: 5.469

3.  POLYRIBOSOMES IN NORMAL AND POLIOVIRUS-INFECTED HELA CELLS AND THEIR RELATIONSHIP TO MESSENGER-RNA.

Authors:  S Penman; K Scherrer; Y Becker; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1963-05       Impact factor: 11.205

4.  Initiation of polyribosome formation in poliovirus-infected HeLa cells.

Authors:  A S Huang; D Balitmore
Journal:  J Mol Biol       Date:  1970-02-14       Impact factor: 5.469

5.  Dynamics of poliovirus-specific RNA synthesis and the effects of inhibitors of virus replication.

Authors:  J Noble; L Levintow
Journal:  Virology       Date:  1970-03       Impact factor: 3.616

6.  Molecular weight of poliovirus ribonucleic acid.

Authors:  N Granboulan; M Girard
Journal:  J Virol       Date:  1969-10       Impact factor: 5.103

7.  Action of guanidine on the replication of poliovirus RNA.

Authors:  L A Caliguiri; I Tamm
Journal:  Virology       Date:  1968-07       Impact factor: 3.616

8.  Aspects of the synthesis of poliovirus RNA and the formation of virus particles.

Authors:  D Baltimore; M Girard; J E Darnell
Journal:  Virology       Date:  1966-06       Impact factor: 3.616

9.  Structure of the poliovirus replicative intermediate RNA.

Authors:  D Baltimore
Journal:  J Mol Biol       Date:  1968-03-14       Impact factor: 5.469

10.  In vitro synthesis of poliovirus ribonucleic acid: role of the replicative intermediate.

Authors:  M Girard
Journal:  J Virol       Date:  1969-04       Impact factor: 5.103

View more
  49 in total

1.  Mechanism for discrimination between viral and host mRNA in interferon-treated cells.

Authors:  T W Nilsen; C Baglioni
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

2.  Determination of the length distribution of poly(A) at the 3' terminus of the virion RNAs of EMC virus, poliovirus, rhinovirus, RAV-61 and CPMV and of mouse globin mRNA.

Authors:  P Ahlquist; P Kaesberg
Journal:  Nucleic Acids Res       Date:  1979-11-10       Impact factor: 16.971

3.  A new method for the isolation of undegraded FMDV-specific RNA from infected BHK cells.

Authors:  E A Scodeller; C D Denoya; C Vasquez; J L La Torre
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

4.  Identification of a protein linked to nascent poliovirus RNA and to the polyuridylic acid of negative-strand RNA.

Authors:  R F Pettersson; V Ambros; D Baltimore
Journal:  J Virol       Date:  1978-08       Impact factor: 5.103

5.  An authentic 3' noncoding region is necessary for efficient poliovirus replication.

Authors:  David M Brown; Christopher T Cornell; Genevieve P Tran; Joseph H C Nguyen; Bert L Semler
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  Structural properties of double-stranded RNAs associated with biological control of chestnut blight fungus.

Authors:  J Tartaglia; C P Paul; D W Fulbright; D L Nuss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

7.  Polyadenylic acid on poliovirus RNA. III. In vitro addition of polyadenylic acid to poliovirus RNAs.

Authors:  D H Spector; D Baltimore
Journal:  J Virol       Date:  1975-06       Impact factor: 5.103

8.  Multiple isoelectric forms of poliovirus RNA-dependent RNA polymerase: evidence for phosphorylation.

Authors:  L J Ransone; A Dasgupta
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

9.  Partial block to transcription of human adenovirus type 2 late genes in abortively infected monkey cells.

Authors:  J M Johnston; K P Anderson; D F Klessig
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

10.  ATP is required for initiation of poliovirus RNA synthesis in vitro: demonstration of tyrosine-phosphate linkage between in vitro-synthesized RNA and genome-linked protein.

Authors:  C D Morrow; J Hocko; M Navab; A Dasgupta
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.